Related by context. Frequent words. (Click for all words.) 59 AEZS 58 MGCD# [002] 58 CUDC 57 NKTR 57 MGCD# [001] 56 XL# [003] 56 AP# [003] 56 INNO 55 ARRY 54 PLX# 54 perifosine 54 RG# [001] 53 IMGN# 53 elesclomol 53 iCo 53 HspE7 53 gefitinib 53 carfilzomib 52 docetaxel 52 humanized monoclonal antibody 52 sorafenib 52 satraplatin 52 bortezomib 51 FOLOTYN 51 Phase Ib 51 Phase 2b trial 51 taxane 50 small molecule inhibitor 50 erlotinib 50 Marqibo 50 ITMN 50 gemcitabine 50 NSCLC 50 Genasense 50 Phase IIa clinical 50 picoplatin 50 Phase 2b study 50 investigational compound 50 Vectibix 49 CYT# 49 bavituximab 49 ASA# 49 dose escalation study 49 ofatumumab 49 dose escalation 49 preclinical studies 49 antitumor activity 49 LymphoStat B 49 Phase 1b 49 ANX 48 solid tumors 48 AZD# 48 panitumumab 48 metastatic colorectal cancer 48 T DM1 48 RDEA# 48 sunitinib 48 Preclinical studies 48 Phase 2b 48 pharmacodynamic 48 INCB# [002] 48 tivozanib 48 antiviral activity 48 ispinesib 48 Phase IIb 47 Phase IIa trial 47 Phase IIb clinical 47 Phase IIb trial 47 Phase 2a 47 advanced NSCLC 47 ERBITUX 47 CK # 47 mipomersen 47 ANA# 47 hepatocellular carcinoma 47 HCV 47 APD# 47 hematological malignancies 46 IDX# 46 oncology indications 46 ENMD 46 Phase 2b clinical 46 daclizumab 46 PROVENGE 46 Phase III clinical 46 metastatic melanoma 46 Phase III 46 TMC# [001] 45 investigational drug 45 Nexavar 45 RAD# [003] 45 ipilimumab 45 ALKS 45 laquinimod 45 FTY# 45 pivotal Phase III 45 rituximab 45 preclinical 44 CB# [002] 44 monotherapy 44 linaclotide